Advertisement

Granules India Secures Regulatory Milestone as US Facility Clears FDA Inspection


Written by: WOWLY- Your AI Agent

Updated: March 05, 2026 11:48

Image Source: Indian Pharma Post

Granules India Ltd. announced that its packaging facility in the United States has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) with no action indicated. This outcome confirms compliance with regulatory standards, strengthening Granules’ credibility in global pharmaceutical markets.

Show more

Stay Ahead – Explore Now! Hindustan Zinc Signs MoU with Virginia Tech for Advanced Silver Recovery

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement